Also, we managed to obtain enough cells from the CSF of a third MS patient which were labeled with FITC-conjugated anti-CCR4 and intracellularly with PE-conjugated anti-IFN-γ and APC-conjugated anti-IL-17. This evidence concerns the gene IFNG and myeloid sarcoma.